Burgess J R, Giles N, Shepherd J J
Department of Diabetes, Royal Hobart Hospital, Tasmania, Australia.
Clin Endocrinol (Oxf). 2001 Nov;55(5):689-93. doi: 10.1046/j.1365-2265.2001.01348.x.
Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant tumour syndrome. It is characterized by primary hyperparathyroidism, pituitary neoplasia and foregut lineage neuroendocrine neoplasia. Malignant thymic carcinoid tumours are an uncommon but important manifestation of MEN 1. Transcervical thymectomy is often advocated as prophylaxis against thymic carcinoids, although there is a paucity of evidence to support the efficacy of this procedure. This is the first report of a malignant thymic carcinoid occurring in an MEN 1 patient following prior parathyroidectomy and transcervical thymectomy. It is concluded that transcervical thymectomy does not reliably provide prophylaxis against thymic carcinoid.
1型多发性内分泌腺瘤病(MEN 1)是一种常染色体显性肿瘤综合征。其特征为原发性甲状旁腺功能亢进、垂体肿瘤以及前肠谱系神经内分泌肿瘤。恶性胸腺类癌肿瘤是MEN 1一种不常见但重要的表现形式。经颈胸腺切除术常被提倡作为预防胸腺类癌的措施,尽管缺乏证据支持该手术的有效性。这是首例关于在接受过甲状旁腺切除术和经颈胸腺切除术后的MEN 1患者中发生恶性胸腺类癌的报告。得出的结论是,经颈胸腺切除术不能可靠地预防胸腺类癌。